Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Cresco Labs Inc. (CRLBF)

OQX · Drug Manufacturers - Specialty & Generic

$0.64-0.03 (-4.54%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$236.3M
P/E (TTM)
EPS
$-0.38
Div Yield
52W Range
$0.54–$2.30
Beta
1.72

Company overview

Next earnings: 2026-08-06(9d)

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

2,900 employeeswww.crescolabs.com

Peers in Healthcare

Cresco Labs Inc. has no peer companies in this window.

Recent press releases

Cresco Labs Inc. has not issued a press release in this window.

SEC filings

All filings →

Cresco Labs Inc. has not filed an SEC document in this window.

Cresco Labs Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
55,470 sh● NEW
20,161 sh-50.0%
113,837 sh0.0%
91,155 sh-1.5%

People at Cresco Labs Inc.

All people →

No officers or directors have been indexed for Cresco Labs Inc..

Quarterly financials

Full financials →
Revenue trend
12/24
$471.8M
NI -$5.3M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.
Cresco Labs Inc. (CRLBF) Stock Quote, Press... | Cayman Journal | Cayman Journal